Satyadivis is one of the leading manufacturers of API's & Intermediates
Our Antidepressant segments is key strength making us pioneer
Generic API’s
SDPPL is currently manufacturing below products and to emerge as global leader we are working on adding more products to our product list. Generic APIs are part of our primary focus area. We respect IPR and do not infringe either product or processes covered by valid patents. Our strong commitment to confidentiality has elicited enquiries and tie-ups for supply of APIs that are migrating to generic status in the near future.
Our API’s are manufactured with good enginered practice and tested by high benchmark to deliver excellence. Our strong technical team enables us to implement efficiency and control measures at every stage to add values to our customers.
API's
Fluoxetine HCL - Antidepressant
Ketorolac Tromethamine - Anti Inflammatory
Oxymetazoline HCL - Vasoconstricotr
Xylometazoline HCL - Vasoconstricotr
Atomoxetine HCL - Antidepressant
Fluvoxamine Maleate - Antidepressant
Clopidogreal Bisulphate - Antiplatelet
Clopidogreal Hydrogen sulphate - Antithrombotic
Fenofibrate - Antilipemic Agent
Pregabalin - Anti Epileptic
Bupropion - Antidepressant
SDPPL will be providing all technical support, regulatory support to ensure our customers smoother functioning throughout entire product life cycle.
We supply Intermediates and Advanced Intermediates for generic API’s that are already out of patent, as also for API’s which are about to enter generic status shortly. Here again through its strong R&D and engineered practice is able to manufacture Advance Intermediates with reduced cost supplying to the market as well as for In-House production. We deliver advanced intermediates to Major customers across the globe.
Intermediate manufactured at SDPPL are being delivered world wide having quality & high volumes. We also support our customers with regulatory requirement and Good Manufacturing Practice.